Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Demyelinating disorders: update on transverse myelitis.

Chitra Krishnan1, Adam I Kaplin, Carlos A Pardo

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Pathology 627, 600 North Wolfe Street, Baltimore, MD 21287-6965, USA.

Current Neurology and Neuroscience Reports
|April 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Nature neuroscience·2026
Same author

Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

Nature neuroscience·2026
Same author

Anti-CD320 Autoantibodies and Central Nervous System Vitamin B12 Deficiency in Idiopathic Myelopathy.

medRxiv : the preprint server for health sciences·2026
Same author

Defining Relapse and Disease Activity in Neurosarcoidosis: A Systematic Review and Proposed Framework.

Neurology. Clinical practice·2026
Same author

TEAM Sarcoidosis: Creating a Multidisciplinary Care Team for Complex Clinical Management.

Chest·2025
Same author

Neurosarcoidosis in Critical Care, Internal, and Pulmonary Medicine: A Practical Approach.

Seminars in respiratory and critical care medicine·2025

Transverse myelitis (TM) is a spinal cord inflammation causing significant disability. Interleukin-6 levels in cerebrospinal fluid may predict TM patient outcomes.

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Transverse myelitis (TM) is a focal inflammatory spinal cord disorder.
  • Histopathologic features include perivascular infiltration, demyelination, and axonal injury.
  • Clinical deficits affect motor, sensory, and autonomic pathways, leading to paralysis and sensory disturbances.

Purpose of the Study:

  • To summarize the clinical features, prognosis, and potential biomarkers of Transverse myelitis.
  • To highlight ongoing research into TM treatment.

Main Methods:

  • Review of existing literature and case series on Transverse myelitis.
  • Analysis of histopathologic findings and clinical manifestations.
  • Evaluation of biomarker studies, specifically focusing on interleukin-6.

Related Experiment Videos

Main Results:

  • Transverse myelitis frequently results in severe neurological deficits, including paraplegia and bladder dysfunction.
  • Prognosis varies, with one-third of patients experiencing mild recovery, one-third moderate disability, and one-third severe disability.
  • Elevated cerebrospinal fluid levels of interleukin-6 correlate strongly with and predict disability in acute TM patients.

Conclusions:

  • Interleukin-6 shows promise as a biomarker for predicting disability in Transverse myelitis.
  • Clinical trials are investigating novel treatments, including axonoprotective agents and intravenous steroids, for TM.